Search Results

U.S. FDA approves Takeda’s ALUNBRIG for lung cancer patients

U.S. FDA Approves Takeda’s ALUNBRIG (brigatinib) as a first-line treatment option for patients diagnosed with rare and serious form of lung cancer ...
May 23